BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wan Z, Zhao L, Lu F, Gao X, Dong Y, Zhao Y, Wei M, Yang G, Xing C, Liu L. Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium. Theranostics 2020;10:218-30. [PMID: 31903116 DOI: 10.7150/thno.38198] [Cited by in Crossref: 44] [Cited by in F6Publishing: 60] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang G, Yang X, Su X, An N, Yang F, Li X, Jiang Y, Xing Y, Bihl J. Understanding the Protective Role of Exosomes in Doxorubicin-Induced Cardiotoxicity. Oxidative Medicine and Cellular Longevity 2022;2022:1-14. [DOI: 10.1155/2022/2852251] [Reference Citation Analysis]
2 You B, Yang Y, Zhou Z, Yan Y, Zhang L, Jin J, Qian H. Extracellular Vesicles: A New Frontier for Cardiac Repair. Pharmaceutics 2022;14:1848. [DOI: 10.3390/pharmaceutics14091848] [Reference Citation Analysis]
3 Wang Z, Mo H, He Z, Chen A, Cheng P. Extracellular vesicles as an emerging drug delivery system for cancer treatment: Current strategies and recent advances. Biomedicine & Pharmacotherapy 2022;153:113480. [DOI: 10.1016/j.biopha.2022.113480] [Reference Citation Analysis]
4 Gu Z, Yin Z, Song P, Wu Y, He Y, Zhu M, Wu Z, Zhao S, Huang H, Wang H, Tong C, Qi Z. Safety and biodistribution of exosomes derived from human induced pluripotent stem cells. Front Bioeng Biotechnol 2022;10:949724. [DOI: 10.3389/fbioe.2022.949724] [Reference Citation Analysis]
5 Wan Z, Gan X, Mei R, Du J, Fan W, Wei M, Yang G, Qin W, Zhu Z, Liu L. ROS triggered local delivery of stealth exosomes to tumors for enhanced chemo/photodynamic therapy. J Nanobiotechnology 2022;20:385. [PMID: 35999549 DOI: 10.1186/s12951-022-01591-7] [Reference Citation Analysis]
6 Ko C, Zang S, Zhou Y, Zhong Z, Yang C. Nanocarriers for effective delivery: modulation of innate immunity for the management of infections and the associated complications. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01582-8] [Reference Citation Analysis]
7 Jiang T, Li Q, Qiu J, Chen J, Du S, Xu X, Wu Z, Yang X, Chen Z, Chen T. Nanobiotechnology: Applications in Chronic Wound Healing. Int J Nanomedicine 2022;17:3125-45. [PMID: 35898438 DOI: 10.2147/IJN.S372211] [Reference Citation Analysis]
8 Sang L, Guo X, Fan H, Shi J, Hou S, Lv Q. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Idiopathic Pulmonary Fibrosis Microenvironment Targeted Delivery. Cells 2022;11:2322. [DOI: 10.3390/cells11152322] [Reference Citation Analysis]
9 Yedavilli S, Singh AD, Singh D, Samal R. Nano-Messengers of the Heart: Promising Theranostic Candidates for Cardiovascular Maladies. Front Physiol 2022;13:895322. [DOI: 10.3389/fphys.2022.895322] [Reference Citation Analysis]
10 Yu X, Chen X, Sun Z, Niu R, Deng Y, Wang L, Zhu Y, Zhang L, Zhang H, Wang K, Yang J, Gu W, Liu G, Luo Y. Ultracentrifugation-Free Enrichment and Quantification of Small Extracellular Vesicles. Anal Chem . [DOI: 10.1021/acs.analchem.1c05491] [Reference Citation Analysis]
11 Arifin DR, Witwer KW, Bulte JWM. Non-Invasive imaging of extracellular vesicles: Quo vaditis in vivo? J Extracell Vesicles 2022;11:e12241. [PMID: 35844061 DOI: 10.1002/jev2.12241] [Reference Citation Analysis]
12 Tang TT, Wang B, Lv LL, Dong Z, Liu BC. Extracellular vesicles for renal therapeutics: State of the art and future perspective. J Control Release 2022:S0168-3659(22)00391-1. [PMID: 35779658 DOI: 10.1016/j.jconrel.2022.06.049] [Reference Citation Analysis]
13 Warashina S, Zouda M, Mohri K, Wada Y, Maeda K, Watanabe Y, Mukai H. 64Cu-labeling of small extracellular vesicle surfaces via a cross-bridged macrocyclic chelator for pharmacokinetic study by positron emission tomography imaging. Int J Pharm 2022;:121968. [PMID: 35772573 DOI: 10.1016/j.ijpharm.2022.121968] [Reference Citation Analysis]
14 Chen H, Sun T, Jiang C. Extracellular vesicle-based macromolecule delivery systems in cancer immunotherapy. J Control Release 2022;348:572-89. [PMID: 35714733 DOI: 10.1016/j.jconrel.2022.06.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhang K, Wang J, Zhu Y, Liu X, Li J, Shi Z, Cao M, Li Y. Identification of Hub Genes Associated With the Development of Stomach Adenocarcinoma by Integrated Bioinformatics Analysis. Front Oncol 2022;12:844990. [PMID: 35686089 DOI: 10.3389/fonc.2022.844990] [Reference Citation Analysis]
16 Liu D, Cheng Y, Qiao S, Liu M, Ji Q, Zhang BL, Mei QB, Zhou S. Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma. ACS Nano 2022. [PMID: 35549164 DOI: 10.1021/acsnano.1c09794] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Panigrahi AR, Srinivas L, Panda J. Exosomes: Insights and therapeutic applications in cancer. Transl Oncol 2022;21:101439. [PMID: 35551002 DOI: 10.1016/j.tranon.2022.101439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tang Y, Wu P, Li L, Xu W, Jiang J. Mesenchymal Stem Cells and Their Small Extracellular Vesicles as Crucial Immunological Efficacy for Hepatic Diseases. Front Immunol 2022;13:880523. [DOI: 10.3389/fimmu.2022.880523] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Mirkasymov AB, Zelepukin IV, Ivanov IN, Belyaev IB, Sh. Dzhalilova D, Trushina DB, Yaremenko AV, Yu. Ivanov V, Nikitin MP, Nikitin PI, Zvyagin AV, Deyev SM. Macrophage Blockade using Nature-Inspired Ferrihydrite for Enhanced Nanoparticle Delivery to Tumor. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121795] [Reference Citation Analysis]
20 Ginini L, Billan S, Fridman E, Gil Z. Insight into Extracellular Vesicle-Cell Communication: From Cell Recognition to Intracellular Fate. Cells 2022;11:1375. [DOI: 10.3390/cells11091375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Ansari MA, Thiruvengadam M, Venkidasamy B, Alomary MN, Alamoudi AJ, Chung IM, Shariati MA, Rebezov M. Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: Current status and future perspectives. Semin Cancer Biol 2022:S1044-579X(22)00099-2. [PMID: 35452820 DOI: 10.1016/j.semcancer.2022.04.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Mills JA, Liu F, Jarrett TR, Fletcher NL, Thurecht KJ. Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation. Biomater Sci 2022. [PMID: 35419582 DOI: 10.1039/d2bm00181k] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Zeng W, Wen Z, Chen H, Duan Y. Exosomes as Carriers for Drug Delivery in Cancer Therapy. Pharm Res. [DOI: 10.1007/s11095-022-03224-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Chen H, Xue R, Huang P, Wu Y, Fan W, He X, Dong Y, Liu C. Modified Exosomes: a Good Transporter for miRNAs within Stem Cells to Treat Ischemic Heart Disease. J Cardiovasc Transl Res 2022. [PMID: 35229250 DOI: 10.1007/s12265-022-10216-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Dehkordi NR, Dehkordi NR, Farjoo MH. Therapeutic properties of stem cell-derived exosomes in ischemic heart disease. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174839] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Fathi I, Miki T. Human Amniotic Epithelial Cells Secretome: Components, Bioactivity, and Challenges. Front Med (Lausanne) 2021;8:763141. [PMID: 35083233 DOI: 10.3389/fmed.2021.763141] [Reference Citation Analysis]
27 Wu X, Jin S, Ding C, Wang Y, He D, Liu Y. Mesenchymal Stem Cell-Derived Exosome Therapy of Microbial Diseases: From Bench to Bed. Front Microbiol 2021;12:804813. [PMID: 35046923 DOI: 10.3389/fmicb.2021.804813] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Yu X, Bai Y, Han B, Ju M, Tang T, Shen L, Li M, Yang L, Zhang Z, Hu G, Chao J, Zhang Y, Yao H. Extracellular vesicle-mediated delivery of circDYM alleviates CUS-induced depressive-like behaviours. J Extracell Vesicles 2022;11:e12185. [PMID: 35029057 DOI: 10.1002/jev2.12185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Li N, Sun Y, Fu Y, Sun K. RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy. Front Pharmacol 2021;12:734443. [PMID: 35002692 DOI: 10.3389/fphar.2021.734443] [Reference Citation Analysis]
30 Motlagh PE, Novin AG, Ghahari F, Nikzad A, Khoshandam M, Mardani S, Khanbabaei H, Farsinejad A, Sathyapalan T, Sahebkar A, Pourghadamyari H. Evaluation of the Effect of Crocin on Doxorubicin-Induced Cardiotoxicity. Adv Exp Med Biol 2021;1328:143-53. [PMID: 34981476 DOI: 10.1007/978-3-030-73234-9_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kuriyama N, Yoshioka Y, Kikuchi S, Okamura A, Azuma N, Ochiya T. Challenges for the Development of Extracellular Vesicle-Based Nucleic Acid Medicines. Cancers (Basel) 2021;13:6137. [PMID: 34885247 DOI: 10.3390/cancers13236137] [Reference Citation Analysis]
32 Maiborodin I, Klinnikova M, Kuzkin S, Maiborodina V, Krasil'nikov S, Pichigina A, Lushnikova E. Morphology of the Myocardium after Experimental Bone Tissue Trauma and the Use of Extracellular Vesicles Derived from Mesenchymal Multipotent Stromal Cells. J Pers Med 2021;11:1206. [PMID: 34834558 DOI: 10.3390/jpm11111206] [Reference Citation Analysis]
33 Wang J, Yu L, Zhou A, Liu J, Wang K, Luo Y, Wang F. Non-Viral Gene Delivery Systems for Treatment of Myocardial Infarction: Targeting Strategies and Cardiac Cell Modulation. Pharmaceutics 2021;13:1520. [PMID: 34575595 DOI: 10.3390/pharmaceutics13091520] [Reference Citation Analysis]
34 Jiang L, Gu Y, Du Y, Tang X, Wu X, Liu J. Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy. ACS Appl Mater Interfaces 2021;13:42411-28. [PMID: 34464081 DOI: 10.1021/acsami.1c10325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Kim H, Jang H, Cho H, Choi J, Hwang KY, Choi Y, Kim SH, Yang Y. Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy. Cancers (Basel) 2021;13:4435. [PMID: 34503245 DOI: 10.3390/cancers13174435] [Reference Citation Analysis]
36 Ackun-Farmmer MA, Xiao B, Newman MR, Benoit DSW. Macrophage depletion increases target specificity of bone-targeted nanoparticles. J Biomed Mater Res A 2021;:e37279. [PMID: 34319645 DOI: 10.1002/jbm.a.37279] [Reference Citation Analysis]
37 Desideri E, Ciccarone F, Ciriolo MR, Fratantonio D. Extracellular vesicles in endothelial cells: from mediators of cell-to-cell communication to cargo delivery tools. Free Radic Biol Med 2021;172:508-20. [PMID: 34214634 DOI: 10.1016/j.freeradbiomed.2021.06.030] [Reference Citation Analysis]
38 Mastrobattista E. Formulation and delivery solutions for the next generation biotherapeutics. J Control Release 2021;336:583-97. [PMID: 34174354 DOI: 10.1016/j.jconrel.2021.06.029] [Reference Citation Analysis]
39 Wang X, Tang Y, Liu Z, Yin Y, Li Q, Liu G, Yan B. The Application Potential and Advance of Mesenchymal Stem Cell-Derived Exosomes in Myocardial Infarction. Stem Cells Int 2021;2021:5579904. [PMID: 34122557 DOI: 10.1155/2021/5579904] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
40 Schulz-Siegmund M, Aigner A. Nucleic acid delivery with extracellular vesicles. Adv Drug Deliv Rev 2021;173:89-111. [PMID: 33746014 DOI: 10.1016/j.addr.2021.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
41 Cao XH, Liang MX, Wu Y, Yang K, Tang JH, Zhang W. Extracellular vesicles as drug vectors for precise cancer treatment. Nanomedicine (Lond) 2021;16:1519-37. [PMID: 34011162 DOI: 10.2217/nnm-2021-0123] [Reference Citation Analysis]
42 Zhang Z, Tang J, Cui X, Qin B, Zhang J, Zhang L, Zhang H, Liu G, Wang W, Zhang J. New Insights and Novel Therapeutic Potentials for Macrophages in Myocardial Infarction. Inflammation 2021. [PMID: 33866463 DOI: 10.1007/s10753-021-01467-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
43 Wang Y, Li C, Zhao R, Qiu Z, Shen C, Wang Z, Liu W, Zhang W, Ge J, Shi B. CircUbe3a from M2 macrophage-derived small extracellular vesicles mediates myocardial fibrosis after acute myocardial infarction. Theranostics 2021;11:6315-33. [PMID: 33995660 DOI: 10.7150/thno.52843] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
44 Wang J, Tang W, Yang M, Yin Y, Li H, Hu F, Tang L, Ma X, Zhang Y, Wang Y. Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy. Biomaterials 2021;273:120784. [PMID: 33848731 DOI: 10.1016/j.biomaterials.2021.120784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
45 Tian C, Yang Y, Bai B, Wang S, Liu M, Sun RC, Yu T, Chu XM. Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity. Int J Biol Sci 2021;17:1328-38. [PMID: 33867849 DOI: 10.7150/ijbs.58786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
46 Yu T, Chu S, Liu X, Li J, Chen Q, Xu M, Wu H, Li M, Dong Y, Zhu F, Zhou H, Hu D, Fan H. Extracellular vesicles derived from EphB2-overexpressing bone marrow mesenchymal stem cells ameliorate DSS-induced colitis by modulating immune balance. Stem Cell Res Ther 2021;12:181. [PMID: 33722292 DOI: 10.1186/s13287-021-02232-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
47 Gao H, Cheng R, A. Santos H. Nanoparticle‐mediated siRNA delivery systems for cancer therapy. VIEW 2021;2:20200111. [DOI: 10.1002/viw.20200111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
48 Li Z, Zhao P, Zhang Y, Wang J, Wang C, Liu Y, Yang G, Yuan L. Exosome-based Ldlr gene therapy for familial hypercholesterolemia in a mouse model. Theranostics 2021;11:2953-65. [PMID: 33456582 DOI: 10.7150/thno.49874] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 18.0] [Reference Citation Analysis]
49 Chen P, Wang L, Fan X, Ning X, Yu B, Ou C, Chen M. Targeted delivery of extracellular vesicles in heart injury. Theranostics 2021;11:2263-77. [PMID: 33500724 DOI: 10.7150/thno.51571] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
50 Ma YS, Yang XL, Xin R, Liu JB, Fu D. Power and promise of exosomes as clinical biomarkers and therapeutic vectors for liquid biopsy and cancer control. Biochim Biophys Acta Rev Cancer 2021;1875:188497. [PMID: 33370570 DOI: 10.1016/j.bbcan.2020.188497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Shao J, Zaro J, Shen Y. Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate. Int J Nanomedicine 2020;15:9355-71. [PMID: 33262592 DOI: 10.2147/IJN.S281890] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
52 Pezzana C, Agnely F, Bochot A, Siepmann J, Menasché P. Extracellular Vesicles and Biomaterial Design: New Therapies for Cardiac Repair. Trends Mol Med 2021;27:231-47. [PMID: 33218944 DOI: 10.1016/j.molmed.2020.10.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
53 de Jong B, Barros ER, Hoenderop JGJ, Rigalli JP. Recent Advances in Extracellular Vesicles as Drug Delivery Systems and Their Potential in Precision Medicine. Pharmaceutics 2020;12:E1006. [PMID: 33105857 DOI: 10.3390/pharmaceutics12111006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
54 Gutierrez-Millan C, Calvo Díaz C, Lanao JM, Colino CI. Advances in Exosomes-Based Drug Delivery Systems. Macromol Biosci 2021;21:e2000269. [PMID: 33094544 DOI: 10.1002/mabi.202000269] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
55 Sun W, Zhao P, Zhou Y, Xing C, Zhao L, Li Z, Yuan L. Ultrasound targeted microbubble destruction assisted exosomal delivery of miR-21 protects the heart from chemotherapy associated cardiotoxicity. Biochem Biophys Res Commun 2020;532:60-7. [PMID: 32828538 DOI: 10.1016/j.bbrc.2020.05.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Bheri S, Hoffman JR, Park HJ, Davis ME. Biomimetic nanovesicle design for cardiac tissue repair. Nanomedicine (Lond) 2020;15:1873-96. [PMID: 32752925 DOI: 10.2217/nnm-2020-0097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Tang TT, Wang B, Lv LL, Liu BC. Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy. Theranostics 2020;10:8111-29. [PMID: 32724461 DOI: 10.7150/thno.47865] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
58 Zheng Y, Hasan A, Nejadi Babadaei MM, Behzadi E, Nouri M, Sharifi M, Falahati M. Exosomes: Multiple-targeted multifunctional biological nanoparticles in the diagnosis, drug delivery, and imaging of cancer cells. Biomed Pharmacother 2020;129:110442. [PMID: 32593129 DOI: 10.1016/j.biopha.2020.110442] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
59 Wei M, Gao X, Liu L, Li Z, Wan Z, Dong Y, Chen X, Niu Y, Zhang J, Yang G. Visceral Adipose Tissue Derived Exosomes Exacerbate Colitis Severity via Pro-inflammatory MiRNAs in High Fat Diet Fed Mice. ACS Nano 2020;14:5099-110. [PMID: 32275391 DOI: 10.1021/acsnano.0c01860] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 18.5] [Reference Citation Analysis]
60 Yang D, Zhang W, Zhang H, Zhang F, Chen L, Ma L, Larcher LM, Chen S, Liu N, Zhao Q, Tran PHL, Chen C, Veedu RN, Wang T. Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics. Theranostics 2020;10:3684-707. [PMID: 32206116 DOI: 10.7150/thno.41580] [Cited by in Crossref: 190] [Cited by in F6Publishing: 204] [Article Influence: 95.0] [Reference Citation Analysis]